Education
About Us
Working with TipRanks
Follow Us
James Rolke Insider Profile
4 Followers
James Rolke, CSO at La Jolla Pharma, holds 410.71K shares in Revelation Biosciences (Ticker: REVB), holds 81.77K shares in La Jolla Pharma (Ticker: LJPC).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-34.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that James Rolke holds in companies
Most Profitable Insider Trade
Stock:
La Jolla Pharma
(LJPC)
(LJPC)
Rating:Informative Buy
Date:Jan 09, 2019 - Jan 09, 2020
Return:-13.70%
The most profitable trade made by James Rolke
James Rolke's Trading History
La Jolla Pharma
Jun 02, 2020
―
Uninformative Buy
822.05
$508.62K
Revelation Biosciences
Oct 31, 2025
CEO, Director
Uninformative Buy
499.99K
$403.31K
List of latest transactions for each holding click on a transaction to see James Rolke's performance on stock
You May Also Like
James Rolke insider profile FAQ
What is the percentage of profitable transactions made by James Rolke?
The percentage of profitable transactions made by James Rolke is 0%.
What is the average return per transaction made by James Rolke?
The average return per transaction made by James Rolke is -34.90%.
What stocks does James Rolke hold?
James Rolke holds: LJPC, REVB stocks.
What was James Rolke’s latest transaction?
James Rolke latest transaction was an Uninformative Buy of $499.99K.
What was James Rolke's most profitable transaction?
James Rolke’s most profitable transaction was an Informative Buy of LJPC stock on January 9, 2019. The return on the trade was -13.70%.
What is James Rolke's role in La Jolla Pharma?
James Rolke's role in La Jolla Pharma is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.